Founded with a vision to accelerate and transform the discovery, development, and manufacturing of biologics, WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO). The company offers integrated technology platforms that encompass antibody generation and engineering, development, manufacturing, and IND filing support. WuXi Biologics focuses on providing comprehensive solutions for biologics drug development, catering to pharmaceutical companies worldwide.
Notable affiliated individuals include members of its leadership team and scientific advisory board, who bring extensive expertise in biotechnology and pharmaceutical industries. WuXi Biologics has achieved significant milestones, such as expanding its global footprint with multiple state-of-the-art facilities and receiving numerous industry awards. The company's impact is evident in its contribution to accelerating biologics development, thereby enhancing the availability of innovative therapies globally.
